SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-046088
Filing Date
2024-11-14
Accepted
2024-11-14 17:27:13
Documents
77
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1238165
2 ex31-1.htm EX-31.1 18528
3 ex31-2.htm EX-31.2 18547
4 ex32-1.htm EX-32.1 8462
5 ex32-2.htm EX-32.2 8546
  Complete submission text file 0001493152-24-046088.txt   7611343

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE cdt-20240930.xsd EX-101.SCH 62528
7 XBRL CALCULATION FILE cdt-20240930_cal.xml EX-101.CAL 73470
8 XBRL DEFINITION FILE cdt-20240930_def.xml EX-101.DEF 313268
9 XBRL LABEL FILE cdt-20240930_lab.xml EX-101.LAB 526746
10 XBRL PRESENTATION FILE cdt-20240930_pre.xml EX-101.PRE 435404
79 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1099804
Mailing Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103 (646) 491 9132
CONDUIT PHARMACEUTICALS INC. (Filer) CIK: 0001896212 (see all company filings)

IRS No.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41245 | Film No.: 241464521
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)